“Children and adolescents are disproportionately affected by mpox in the ongoing outbreak in Africa, highlighting the importance and urgency of broadening access to vaccines and therapies for this vulnerable population,” said Bavarian Nordic CEO Paul Chaplin in a statement.
The European Medicines Agency (EMA) is now reviewing the submitted data, and the company anticipates that the vaccine’s marketing authorisation could be extended to include adolescents during the fourth quarter of 2024.
NigeriaDNA is a Direct News source that delivers the latest news, buzz, and stories from some of Nigeria’s most popular and trusted news websites. NigeriaDNA facilitates this by publishing headlines linking to breaking news and curated snippets from a diverse range of Nigerian credible, independent, and public-interest news sources. Our editors make it easy for Nigerians abroad and diaspora to discover top news stories in real-time as they're posted and directly linked to Nigeria's authoritative News Sources.
© 2025 All Rights Reserved | Curated and Powered by Nigeria DNA
